In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Leadership

Set Alert for Leadership

Aetion: Sealing The Deal With Payers On Real-World Research

As biopharma’s embrace of real-world evidence (RWE) gathers speed, In Vivo looks at one company that is using a mix of prestigious academic, government and non-profit partners to build a credible foundation for acceptance of this research tool in the wider commercial space. 

Innovation Strategy Reimbursement
Advertisement

Latest From Leadership

Getting A Grip On Costs In Medtech: The Role Of Culture Change And Leadership Support

Consolidation of hospital networks and professionalization of purchasing teams are putting pressure on medtech prices, and they are just two of the factors that are encouraging medtech leaders to renew their focus on spending visibility and accountability. Zero-based budgeting is a tool that could help them deliver a triple win, Patrick O’Hagan and Jason Evers of Bain & Company suggest.

Leadership Financing

Top 10 Most Read Stories Of 2018

Patient access, regenerative medicine and immuno-oncology feature heavily in a list of the Top 10 most read In Vivo features from 2018, highlighting the issues and disease areas that are top of mind for biopharma and medtech leaders.

Leadership BioPharmaceutical

Into 2019: Stakeholders Are Bidding To Re-Engage Medtech's Innovative Engine

"All-hands-on-deck" has been the policy pursued by the US industry association AdvaMed in recent times, as it has sought to play its part in promoting user-friendly, responsive and transparent regulation and market access for medical and digital health care technology. AdvaMed chair Nadim Yared believes that, with one or two noteworthy exceptions, there is more to come in 2019 from a largely improving medtech ecosystem globally.

US States Leadership

Execs On The Move, Dec 2018

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Leadership

Lessons From A Life Sciences Lifetime: An Interview With Sir John Bell

Professor Sir John Bell talks to In Vivo about how the life sciences sector has evolved during his career, lessons he has learned along the way, and the biggest challenges and changes ahead for the industry in 2019.

Leadership Outlook 2019

Brexit And Cooperation: Insights From Danish Medicines Agency Head Thomas Senderovitz

It was inevitable that Brexit would be the key theme of an interview with Danish Medicines Agency head Thomas Senderovitz earlier this year. The senior European regulator oversees one of the agencies that has taken on new staff to help deal with the impact, in drug regulatory terms, of the vote by the UK in June 2016 to leave the European Union. Senderovitz also chairs the management group of the EU Heads of Medicines Agencies network.

Leadership Policy & Regulation
See All
UsernamePublicRestriction

Register